The AJMC® Ophthalmology compendium is a comprehensive resource for clinical news and expert insights for treatment of disorders of the eye.
April 21st 2025
The complete response letter (CRL) specifies that the current dosage duration of aflibercept is still safe but extending the duration is not approved.
Application of Recent Data in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Managed Care Insights and Strategies
1.5 Credits / Ophthalmology, Optometry
View More
Leveraging Novel Therapies to Transform Demodex Blepharitis Care
May 13, 2025 | 7:00 PM ET
View More
Patient-Centered Treatment Plans for Management of Neovascular (Wet) AMD and Diabetic Macular Edema: Insights on Recent Efficacy, Safety, and Real-World Data to Improve Adhere...
1.5 Credits / Ophthalmology/Optometry
View More
Leveraging Novel Therapies to Transform Demodex Blepharitis Care (6/11)
Jun 11, 2025 1:00 PM ET
View More
Integrating Multi-Cancer Early Detection Tests Into Clinical Practice: The Health Economics Perspective for Managed Care Professionals
1.5 Credits / Oncology
View More
The Evolving Strategies for Managing nAMD and DME: Empowering Managed Care Decisions for Improved Patient Outcomes
1.5 Credits / Endocrinology, Diabetes & Metabolism, Ophthalmology/Optometry
View More
Anti-VEGF Treatment Provides Long-Term Treatment in Diabetic Macular Edema
February 12th 2024Although corticosteroids were found to immediately improve best-corrected visual acuity and central macular thickness, anti–vascular endothelial growth factor (anti-VEGF) therapies had significant long-term advantages when treating diabetic macular edema.
Read More
CMS released the proposed 2025 Advance Notice for the Medicare Advantage (MA) and Medicare Part D Prescription Drug Programs; there have been 561 deaths related to the use of Philips’ recalled ventilators and machines for treating obstructive sleep apnea since 2021; the FDA warned the public against copycat eye drops due to infection risk.
Read More
Ultrasound Cycloplasty, Endoscopic Cyclophotocoagulation Can Reduce IOP in Secondary Glaucoma
January 17th 2024Endoscopic cyclophotocoagulation had better effect at early stages and ultrasound cycloplasty had higher safety and tolerance when treating intraocular pressure (IOP) in patients with secondary glaucoma.
Read More
Improving Eye Care Through Community Service With the UPMC eyeVan
January 12th 2024Amrish Selvam is a fourth-year medical student at the University of Pittsburgh whose research and career interests lay in ophthalmology and who volunteers with the UPMC Vision Institute’s mobile eye clinic, the eyeVan.
Watch
UPMC’s eyeVan Expands Accessible Eye Care by Addressing Health Equity Barriers
January 5th 2024In this interview with Katie Cecconi, community service program coordinator at the UPMC Vision Institute, we learn more about the institute’s mobile eye care initiatives and how its services are working to overcome care equity gaps.
Watch
Faricimab Increases Fluid-Free Interval, Extends Dosing Interval in Patients With AMD
December 12th 2023Patients with age-related macular degeneration (AMD) who were not responsive to anti–vascular endothelial growth factor agents were able to increase their fluid-free intervals with faricimab.
Read More
Eye Changes After Cataract Surgery Associated With Diabetic Retinopathy
December 11th 2023Patients receiving uncomplicated phacoemulsification surgery for cataracts had greater increases in macular and choroidal thickness if they had early diabetic retinopathy without preoperative diabetic macular edema.
Read More
Poor 1-Month BCVA After Intravitreal Injection Was Primary Predictor of Blindness
November 20th 2023Patients with retinal vein occlusion-related macular edema had a higher likelihood of blindness and low vision if they had low best-corrected visual acuity after 1 month of intravitreal treatment.
Read More